Genetic Technologies Share Price and Company Fundamentals
Last traded: Yesterday at 6:10 AM
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.
|Primary activities||Licensing of biotechnology patents covering the non-coding regions of the genome and other genetic research and testing.|
|Industry / Sector||Diagnostics & Research / Healthcare|
|Mailing address||60-66 Hanover Street Fitzroy VIC 3065 Australia|
|Phone / Fax||61 3 8412 7000 / 61 3 8412 7040|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Genetic Technologies does not pay dividends.
As of Jul 2021, following are the company executives and directors listed on Genetic Technologies.
|Mr. Stanley Sack||Chief Operating Officer||56||318.28k|
|Dr. Richard Allman||Chief Scientific Officer||60||188.21k|
|Dr. Jerzy Muchnicki MBBS||Chief Medical Officer & Exec. Director||63||153.11k|
|Mr. Simon Morriss||Chief Exec. Officer|
|Mr. Michael Tonroe B.Sc., F.C.A., M.A.I.C.D., Bsc(Hons), ACA, MAICD||Chief Financial Officer||53|
|Mr. Paul Keith Mathieson Viney B. Bus, FCPA, FGIA, FCI||Consultant|
|Mr. Carl S. Stubbings BSc||Chief Commercial Officer|
|Mr. Justyn Stedwell||Company Sec.||39|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Genetic Technologies is 72.13M and its enterprise value is 50.03M. The enterprise value to revenue ratio of GTG is 1,945.47.
The GTG's stocks Beta value is 0.87 making it 13% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Genetic Technologies (GTG)
Genetic Technologies (ASX:GTG) Frequently Asked Questions
1. What is Genetic Technologies's Stock Symbol?
Genetic Technologies trades on ASX under the ticker symbol "GTG".
2. What is Genetic Technologies's stock price today?
One share of GTG stock can currently be purchased for approximately $0.008.
3. How can I contact Genetic Technologies?
Genetic Technologies's mailing address is 60-66 Hanover Street Fitzroy VIC 3065 Australia. The company can be reached via phone at 61 3 8412 7000.
4. What is Genetic Technologies's official website?
The official website of Genetic Technologies is http://www.gtglabs.com.
5. Which share registry manages Genetic Technologies's stock?
Genetic Technologies's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.